Larotrectinib is a

January 11, 2022

2 Views

Larotrectinib is a

Q. Larotrectinib is a

A. NTRK inhibitor

B. RET inhibitor

C. cMYC inhibitor

D. Bcl-2 inhibitor

Answer: NTRK inhibitor

Larotrectinib is a

Previous

Crizotinib has activity against which of the following mutations

Larotrectinib is a

Next

Which of the following is the treatment of choice in V 600E BRAF-mutant NSCLC?

Related Articles

What is the most common type of bladder cancer?

What is the most common type of bladder cancer?

All of the below are symptoms of advanced bladder cancer except which one?

All of the below are symptoms of advanced bladder cancer except which one?

True or false? Bladder cancer affects mostly young women

True or false? Bladder cancer affects mostly young women

Which region in the u.s. Has the highest incidence rate of bladder cancer?

Which region in the u.s. Has the highest incidence rate of bladder cancer?

We will be happy to hear your thoughts

Leave a reply Cancel reply

You must be logged in to post a comment.